Harrow Health 10K Form
7 Day Trial
ALL ACCESS PASS
10K form not available
Receive HROW News And Ratings
See the #1 stock for the next 7 days that we like better than HROW
HROW Financial Statistics
Sales & Book Value
|Price / Cash Flow:||0|
|Price / Book:||22.58|
|Net Income (TTM):||$-14.09M|
|Return on Equity:||-125.91%|
|Return on Assets:||-12.8%|
Harrow Health Earnings Forecast
Key Harrow Health Financial Ratios
- The Gross Profit Margin over the past 16 years for HROW is 71.34%.
- The Selling, General & Administrative Expenses for HROW have been equal to 65.73% of Gross Profit Margin.
- The Research & Development expenses have been 3.44% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of HROW is -15.90% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 9 years.
Harrow Health Stock Price Chart
Industry, Sector and Symbol
|Industry:||Drug Manufacturers - Specialty & Generic|
|Trailing P/E Ratio:||0|
|Forward P/E Ratio:||0|
HROW Technical Analysis vs Fundamental Analysis
Harrow Health (HROW) is a Buy
Is Harrow Health a Buy or a Sell?
Harrow Health stock is rated a Buy
The current Harrow Health [HROW] share price is $20.80. The Score for HROW is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.